Beginner Guide
What Are Metabolic Peptides?
A beginner overview of metabolic peptides, including incretin agonists, fat-metabolism tools, and exercise-mimetic research compounds.
Metabolic Peptides in Plain Language
Metabolic peptides and compounds are research tools that interact with the body's energy regulation systems — appetite signaling, fat metabolism, insulin secretion, and energy expenditure. The OSYRIS Metabolic category contains three distinct approaches:
Incretin agonists (GLP-1/2/3, Cagrilinitide) activate hormone receptors involved in appetite, insulin, and glucose regulation. The GLP series offers single, dual, and triple receptor targeting for comparative research.
Direct fat metabolism tools (AOD-9604) act on fat tissue directly — stimulating fat breakdown and inhibiting fat formation without affecting appetite or insulin.
Exercise mimetics (SLU-PP-32, MOTS-C cross-listed from Longevity) activate metabolic pathways normally triggered by exercise — AMPK or ERR signaling.
What's in the OSYRIS Metabolic Category
| Compound | Approach | Key Target |
|---|---|---|
| GLP-1 (S) | Single incretin agonist | GLP-1 receptor |
| GLP-2 (T) | Dual incretin agonist | GIP + GLP-1 receptors |
| GLP-3 (R) | Triple incretin agonist | GIP + GLP-1 + Glucagon receptors |
| Cagrilinitide | Amylin agonist | Amylin receptors (brainstem) |
| AOD-9604 | Direct lipolysis | Beta-3 adrenergic receptors |
| SLU-PP-32 | Exercise mimetic | ERR nuclear receptors |
Where to Go Next
Featured Links
Explore how incretin agonists, amylin signaling, direct lipolysis, and exercise-mimetic pathways fit together.
Read → Shop Collection Metabolic CollectionBrowse the OSYRIS metabolic lineup, from GLP analogs to AOD-9604 and SLU-PP-32.
Browse → Beginner Guide What Are Research Peptides?Start with the broad primer on what peptides are, how they are studied, and why RUO context matters.
Read →Questions
Common Questions
What are incretin agonists?
Compounds that activate the same receptors as incretin hormones (GLP-1, GIP) — gut hormones that regulate insulin, appetite, and glucose metabolism after eating.
Why does OSYRIS have three GLP compounds?
To enable systematic comparison of single (GLP-1 only), dual (GIP + GLP-1), and triple (GIP + GLP-1 + glucagon) receptor targeting.
What is an exercise mimetic?
A compound that activates metabolic pathways normally triggered by exercise, allowing researchers to study which exercise benefits are pathway-specific.
Are these the same as Ozempic?
No. OSYRIS metabolic compounds are research-grade for laboratory use. They are not pharmaceutical products.
Which has the strongest evidence?
GLP-1 (S) and GLP-2 (T) — both backed by extensive Phase 3 clinical trials of their pharmaceutical equivalents.
Can different metabolic approaches be combined?
Yes — they target non-overlapping pathways (appetite vs direct lipolysis vs exercise pathways).
